Tixagevimab (AZD8895) is a human monoclonal antibody designed to target the receptor binding domain (RBD) of SARS-CoV-2. It effectively neutralizes the virus by binding to the RBD as well as the S-glycoprotein ectodomain, thereby inhibiting the S-glycoprotein-mediated attachment to the host cell receptor. This antibody is pivotal for research focused on the mechanisms of viral entry and the development of therapeutic strategies against SARS-CoV-2.
Tixagevimab (AZD8895) is a human monoclonal antibody designed to target the receptor binding domain (RBD) of SARS-CoV-2. It effectively neutralizes the virus by binding to the RBD as well as the S-glycoprotein ectodomain, thereby inhibiting the S-glycoprotein-mediated attachment to the host cell receptor. This antibody is pivotal for research focused on the mechanisms of viral entry and the development of therapeutic strategies against SARS-CoV-2.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
